Product
Supplier
Encyclopedia
Inquiry

EN

Home > Chemical News > Pharma News
ECHEMI chemical news

Pharma News

Facing Omicron, Where is the Next

Facing Omicron, Where is the Next "Special Medicine"?

The COVID-19 outbreak started in early 2020 and has not completely disappeared. The new coronavirus is constantly mutating, among which Omicron has become the main epidemic strain in the world.
Omicron medicine

2022-05-27

Week 21 Partial Veterinary Drug Quotes 2

Week 21 Partial Veterinary Drug Quotes 2

Monosulfate kanamycin, the market inquiry is small, the transaction volume is small, the market price is 305, the actual transaction price is negotiable
Analysis of The Veterinary Drug Raw Material Market in the 21st Week

Analysis of The Veterinary Drug Raw Material Market in the 21st Week

Florfenicol, the price has risen steadily, the market has returned to rationality, and the market quotation is above 455
AstraZeneca's Selumetinib Capsules Received CDE Priority Review

AstraZeneca's Selumetinib Capsules Received CDE Priority Review

Today, the CDE official website announced that AstraZeneca's Selumetinib Capsules will be included in priority review. Selumetinib is the world's first drug approved for the treatment of neurofibromatosis type 1 plexiform neurofibromas (PN) in pediatric
Pfizer to Sell All Drugs at Cost in Low-income Countries

Pfizer to Sell All Drugs at Cost in Low-income Countries

On May 25, Pfizer plans to sell all of its drug portfolio at cost in as many as 45 low-income countries. The program, which will initially launch in five African countries
Pfizer drug vaccine

2022-05-25

Reduced the Risk of Disease Progression by 71% Innovative Anti-cancer Therapy Reached Phase 3 Clinical Endpoint

Reduced the Risk of Disease Progression by 71% Innovative Anti-cancer Therapy Reached Phase 3 Clinical Endpoint

Today, SpringWorks Therapeutics announced that its oral specific gamma-secretase small molecule inhibitor nirogacestat met the primary endpoint in a Phase 3 clinical trial in patients with progressive disease (desmoid tumors)
anti cancer therapy

2022-05-25

Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in China

Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in China

On May 23, Roche announced that its innovative drug crovalimab has achieved positive results in a phase III clinical study (COMMDORE 3) for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH)
EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster

EU Approves AstraZeneca's COVID-19 Vaccine Vaxzevria as Adult Booster

On May 23, AstraZeneca said its new crown vaccine Vaxzevria had been approved by the European Medicines Agency (EMA) as a booster vaccine for adults.
CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List

CanSino's New covid-19 Vaccine is Included in the World Health Organization's Emergency Use List

On May 19, 2022, Beijing time, the World Health Organization released information on its official website, officially listing CanSino Bio’s recombinant covid-19 vaccine
The First! Blockbuster Anti-inflammatory Drugs Gain New Indications

The First! Blockbuster Anti-inflammatory Drugs Gain New Indications

On May 21, the U.S. FDA announced that it approved the expanded indication of Dupixent (dupilumab), a blockbuster IL-4/IL-13 inhibitor jointly developed by Sanofi and Regeneron
Anti-inflammatory

2022-05-23

Sanofi's Innovative Cardiovascular Drug Dolivir Launched in China

Sanofi's Innovative Cardiovascular Drug Dolivir Launched in China

On May 22, 2022, Sanofi China announced that its innovative drug in the cardiovascular field, Dolivi® Clopidogrel Aspirin Tablets
ECHEMI Partner
Suggestions
Email:
Message:
Send Message